1 |
Zetterberg H, Burnham SC. Blood-based molecular biomarkers for Alzheimer's disease. Mol Brain. 2019;12:26. https:// doi.org/10.1186/s13041-019-0448-1.
DOI
|
2 |
Kieboom BCT, Licher S, Wolters FJ, Ikram MK, Hoorn EJ, Zietse R, et al. Serum magnesium is associated with the risk of dementia. Neurology. 2017;89:1716-1722. https://doi.org/10.1212/ WNL.0000000000004517.
DOI
|
3 |
Shen Y, Ye B, Chen P, Wang Q, Fan C, Shu Y, et al. Cognitive decline, dementia, Alzheimer's disease and presbycusis: examination of the possible molecular mechanism. Front Neurosci. 2018;12:394. https://doi.org/10.3389/fnins.2018.00394.
DOI
|
4 |
Khan AA, Quinn TJ, Hewitt J, Fan Y, Dawson J. Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age (Dordr). 2016;38:16. https://doi.org/10.1007/s11357-016-9871-8.
DOI
|
5 |
Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health. 2014;14:643. https://doi.org/10.1186/1471-2458-14-643.
DOI
|
6 |
Vintimilla RM, Large SE, Gamboa A, Rohlfing GD, O'Jile JR, Hall JR, et al. The link between potassium and mild cognitive impairment in Mexican-Americans. Dement Geriatr Cogn Dis Extra. 2018;8:151-157. https://doi.org/10.1159/000488483.
DOI
|
7 |
Wang HX, MacDonald SW, Dekhtyar S, Fratiglioni L. Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: a community-based cohort study. PLoS Med. 2017;14:E1002251.
DOI
|
8 |
Kang Y, Na DL, Hahn S. A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients. J Korean Neuropsychiatr Assoc. 1997;15:300-308.
|
9 |
Kim JM, Prince MJ, Shin IS, Yoon JS. Validity of Korean form of Geriatric depression scale (KGDS) among cognitively impaired Korean elderly and development of a 15-item short version (KGDS-15). Int J Met Psychiatr Res. 2001;10:204-210. https://doi.org/10.1002/mpr.117.
DOI
|
10 |
Kim JM, Shin IS, Yoon JS, Lee HY. Comparison of diagnostic validities between MMSE-K and K-MMSE for screening of dementia. J Korean Neuropsychiatr Assoc. 2002;42:124-130.
|
11 |
Oh E, Kang Y, Shin JH, Yeon BK. A validity study of K-MMSE as a screening test for dementia: comparison against a comprehensive neuropsychological evaluation. Dement Neurocognitive Disord. 2010;9:8-12.
|
12 |
Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009;73:1738-1745.
DOI
|
13 |
Svensson T, Sawada N, Mimura M, Nozaki S, Shikimoto R, Tsugane S. The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up. Transl Psychiatry. 2019;9:26. https://doi.org/10.1038/s41398-018-0336-y.
DOI
|
14 |
Sheline Y, Kehr C. Cost and utility of routine admission laboratory testing for psychiatric inpatients. Gen Hosp Psychiatry. 1990 ;12:329-34.
DOI
|
15 |
Mills JH, Megerian CA, et al. Presbyacusis and presbyastasis. In: Snow JB, Wackym, editors. Ballenger's manual of otorhinolaryngology head and neck surgery. 17th ed. Shelton: People's medical publishing house; 2009. p333-343.
|
16 |
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673-2734. https://doi.org/10.1016/S0140-6736 (17)31363-31366.
DOI
|
17 |
Ozawa M, Ninomiya T, Ohara T, Hirakawa Y, Doi Y, Hata J, et al, Self-reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama Study. J Am Geriatr Soc. 2012;60:1515-1520.
DOI
|
18 |
Sims Wright R, Levy SA, Katzel LI, Rosenberger WF, Manukyan Z, Whitfield KE. Fasting glucose and glucose tolerance as potential predictors of neurocognitive function among nondiabetic older adults. J Clin Exp Neuropsychol. 2015;37:49-60. https://doi.org/10.1080/13803395.2014.985189.
DOI
|
19 |
Anfinson TJ, Kathol RG. Screening laboratory evaluation in psychiatric patients: a review. Gen Hosp Psychiatry. 1992;14:248-257.
DOI
|
20 |
Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale (GDS) for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-1139. https://doi.org/10.1176/ajp.139.9.1136.
DOI
|
21 |
Hyman BT. New neuropathological criteria for Alzheimer disease. Arch Neurol. 1998;55:1174-1176. https://doi.org/10.1001/ archneur.55.9.1174.
DOI
|
22 |
Heller S, Steinberg A, Sedler M. Validation of the english version of the multimodal assessment of capacities in severe dementia (MAC-SD): A cognitive and functional scale for use in severe dementia. J Alzheimers Dis Rep. 2017;1:249-262. https:// doi.org/10.3233/ADR-170038.
DOI
|
23 |
Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, et al. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One 2008;3:e3135. https:// doi.org/10.1371/journal.pone.0003135.
DOI
|
24 |
Gallardo G, Schluter OM, Sudhof TC. A molecular pathway of neurodegeneration linking alpha-synuclein to Apo E and A beta peptides. Nat Neurosci. 2008;11:301-308.
DOI
|
25 |
Choi SH, Na DL, Lee BH, Hahm D, Jeong JH, Yoon SJ, et al. Estimating the validity of the Korean version of expanded Clinical Dementia Rating (CDR) Scale. J Korean Neurol Assoc. 2001;19:585-591.
|